Michigan Drug Discovery
  • About
    • What we do
    • Staff
    • Executive Committee
    • MDD Scientific Advisory Board
    • Affiliates
    • Campus Partners
  • Resources
    • Drug Discovery Roadmap
    • Drug Discovery Research Cores
    • Our Funding Opportunities
    • U-M Funding Opportunities
    • Consulting Services
    • External Resources
    • Internal Resources
  • External Partners
  • Highlighted Projects
  • Recent News
  • Contact Us
  • Support Us
Select Page
Cardiovascular diseases

Cardiovascular diseases

Feb 3, 2020

Cardiovascular diseases Development of calcium pump activators for the treatment of heart failure Heart failure (HF) is the leading cause of morbidity in the United States. Mortality rates remain high with only modest improvements in survival over the past decades,...

Recent Posts

  • Leukemia treatment based on U-M research gets FDA approval
  • Join us on Wednesday, October 1st, 2025 for the 5th Annual Drug Discovery Symposium!
  • Courage Therapeutics receives $7.8M investment to advance weight regulation drugs
  • Integrated stress response plasticity governs normal cell adaptation to chronic stress via the PP2A-TFE3-ATF4 pathway
  • A first-in-class selective inhibitor of EGFR and PI3K offers a single-molecule approach to targeting adaptive resistance
UM Drug Discovery Logo

Michigan Drug Discovery is a campus-spanning program established to mentor, support, identify, and coordinate resources for investigators with an interest in pursuing drug discovery research.

University of Michigan | Michigan Medicine
© Copyright 2019 Regents of the University of Michigan | Privacy Statement | Non-discrimination policy
Nonprofit web design by Boxcar Studio

Michigan Drug Discovery
Mary Sue Coleman Hall
210 Washtenaw Avenue, Rm. 4403
Ann Arbor, MI 48109-2216

Contact Us
Support Us